Invesco Biotechnology & Genome ETF
PBE
PBE
102 hedge funds and large institutions have $78.5M invested in Invesco Biotechnology & Genome ETF in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
+7
Holders Change %
+7.37%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
30
Reduced
23
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
EH
Equitable Holdings
New York
|
$2.33M |
2 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
$1.77M |
3 |
LPL Financial
San Diego,
California
|
$6.28M |
4 |
CW
CreativeOne Wealth
Overland Park,
Kansas
|
$2.61M |
5 |
UBS Group
Zurich,
Switzerland
|
$5.63M |